Double conditional human embryonic kidney cell line based on FLP and ΦC31 mediated transgene integration

Overview of attention for article published in BMC Research Notes, October 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent: 7 patents

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

T-CELL RECEPTORS DIRECTED AGAINST THE PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA AND…

Application EP-4219544-A1

European Patent Office

T-CELL RECEPTORS DIRECTED AGAINST THE PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA AND…

Application EP-4201955-A1

European Patent Office

METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES

Application EP-3569253-A1

European Patent Office

DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION

Application WO-2017106185-A2

World Intellectual Property Organisation (WIPO)

METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS

Application WO-2016100241-A2

World Intellectual Property Organisation (WIPO)

METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS

Application WO-2016100236-A2

World Intellectual Property Organisation (WIPO)

MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF

Application WO-2014164348-A2

World Intellectual Property Organisation (WIPO)